SEARCH

SEARCH BY CITATION

References

  • Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA (2012) Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 23, 2125.
  • Akase T, Shimada T, Terabayashi S, Ikeya Y, Sanada H, Aburada M (2011) Antiobesity effects of Kaempferia parviflora in spontaneously obese type II diabetic mice. J. Nat. Med. 65, 7380.
  • Akase T, Nagase T, Huang L, Ibuki A, Minematsu T, Nakagami G, Ohta Y, Shimada T, Aburada M, Sugama J, Sanada H (2012) Aging-like skin changes induced by ultraviolet irradiation in an animal model of metabolic syndrome. Biol Res Nurs. 14, 180187.
  • Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237, 268275.
  • Baxter JD, Funder JW, Apriletti JW, Webb P (2004) Towards selectively modulating mineralocorticoid receptor function: lessons from other systems. Mol. Cell. Endocrinol. 217, 151165.
  • Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789799.
  • Dröge W, Schipper HM (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6, 361370.
  • Fadini GP, Ceolotto G, Pagnin E, de Kreutzenberg S, Avogaro A (2011) At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell 10, 1017.
  • Farman N, Maubec E, Poeggeler B, Klatte JE, Jaisser F, Paus R (2010) The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon? Exp. Dermatol. 19, 100107.
  • Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244254.
  • Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92105.
  • Frisard M, Ravussin E (2006) Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine 29, 2732.
  • Fujita T (2010) Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 55, 813818.
  • Golden TR, Hinerfeld DA, Melov S (2002) Oxidative stress and aging: beyond correlation. Aging Cell 1, 117123.
  • Goto M (2008) Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends. 2, 218230.
  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 27352752.
  • Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK (2008) Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 117, 22532261.
  • Hirata A, Maeda N, Hiuge A, Hibuse T, Fujita K, Okada T, Kihara S, Funahashi T, Shimomura I (2009) Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc. Res. 84, 164172.
  • Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, Kuwano H, Takeuchi T, Izumi T (1999) Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 48, 11831191.
  • Hopps E, Noto D, Caimi G, Averna MR (2010) A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis. 20, 7277.
  • Inomata S, Matsunaga Y, Amano S, Takada K, Kobayashi K, Tsunenaga M, Nishiyama T, Kohno Y, Fukuda M (2003) Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol. 120, 128134.
  • Kenouch S, Lombes M, Delahaye F, Eugene E, Bonvalet JP, Farman N (1994) Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J. Clin. Endocrinol. Metab. 79, 13341341.
  • Keyse SM, Tyrrell RM (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl Acad. Sci. USA 86, 99103.
  • Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517554.
  • Matsumoto Y, Ogawa Y, Yoshida R, Shimamori A, Kasai H, Ohta H (2008) The stability of the oxidative stress marker, urinary 8-hydroxy-2'- deoxyguanosine (8-OHdG), when stored at room temperature. J Occup Health. 50, 366372.
  • McManus F, McInnes GT, Connell JM (2008) Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist. Nat. Clin. Pract. Endocrinol. Metab. 4, 4452.
  • Mitts TF, Bunda S, Wang Y, Hinek A (2010) Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin. J Invest Dermatol. 130, 23962406.
  • Mulatero P, Milan A, Williams TA, Veglio F (2006) Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem. 4, 7591.
  • Nagase M (2010) Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol. 14, 303314.
  • Nagase M, Fujita T (2008) Aldosterone and glomerular podocyte injury. Clin Exp Nephrol. 12, 233242.
  • Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T (2006) Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J. Am. Soc. Nephrol. 17, 34383446.
  • Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T (2007) Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 50, 877883.
  • National Research Council (1996) Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
  • Oberyszyn TM, Tober KL, Ross MS, Robertson FM (1998) Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation. Mol. Carcinog. 22, 1625.
  • Odermatt A, Atanasov AG (2009) Mineralocorticoid receptors: emerging complexity and functional diversity. Steroids 74, 163171.
  • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709717.
  • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 13091321.
  • Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL, Sauder DN (2006) Photoaging: mechanisms and repair. J. Am. Acad. Dermatol. 55, 119.
  • Roberts CK, Sindhu KK (2009) Oxidative stress and metabolic syndrome. Life Sci. 84, 705712.
  • Sainte Marie Y, Toulon A, Paus R, Maubec E, Cherfa A, Grossin M, Descamps V, Clemessy M, Gasc JM, Peuchmaur M, Glick A, Farman N, Jaisser F (2007) Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. Am. J. Pathol. 171, 846860.
  • Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T (2008) Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14, 13701376.
  • Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, Sato T, Endo T, Kawamura H (1999) A new mouse model of spontaneous diabetes derived from ddY strain. Exp. Anim. 48, 181189.
  • Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, Lumeng CN, Mortensen RM (2010) Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest. 120, 33503364.
  • Zennaro MC, Caprio M, Feve B (2009) Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol. Metab. 20, 444451.